查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1514895

疟疾和镰状细胞疾病治疗市场，按疾病、药物类型、给药途径、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Malaria and Sickle Cell Disease Treatment Market, By Disease, By Drug Type, By Route of Administration, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 388 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023年疟疾和镰状细胞疾病治疗市场规模为56.1136亿美元，2024年至2032年复合年增长率为25.9%。

疟疾和镰状细胞疾病治疗市场-市场动态

疟疾和镰状细胞疾病高发生率的治疗进展

在疟疾和镰状细胞疾病高盛行率的情况下，治疗取得进展对于解决这些疾病造成的重大全球健康负担至关重要。例如，根据世界卫生组织 (WHO) 的统计，疟疾每年影响全球超过 2 亿人。据镰状细胞疾病联盟称，全世界每年估计有 30 万名儿童出生时患有镰状细胞疾病 (SCD)。到2050 年，这一数字预计将增加到40 万。 。最近的突破包括他非诺喹等新型抗疟药物的批准，以及针对镰状细胞疾病的有前途的基因编辑疗法的出现，凸显了医疗保健领域的进步有可能减轻这些疾病对全世界受影响人群的负担。

疟疾和镰状细胞疾病治疗市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 25.9% 左右的复合年增长率成长

根据疾病细分，镰状细胞疾病预计将在 2023 年显示最大的市场份额

依药品类型细分，2023年抗疟药为主导类型

按地区划分，亚太地区是 2023 年的主要收入来源

疟疾和镰状细胞疾病治疗市场-細項分析：

全球疟疾和镰状细胞疾病治疗市场根据疾病、药物类型、给药途径和地区进行细分。

市场依疾病分为两类：疟疾和镰状细胞疾病。疟疾优先考虑速效药物来应对不断增加的病例和抗药性，并专注于高负担地区。相反，镰状细胞片段的目标是长期管理慢性症状和改善患者的生活品质。

根据药物类型，市场分为三类：抗疟药物、疼痛管理药物和疾病缓解疗法。抗疟药物占主导地位，针对的是寄生虫本身。疼痛管理药物可解决镰状细胞疾病的关键症状。最有前途的部分是疾病修饰疗法，有可能减缓疾病进展并改善长期结果。

疟疾和镰状细胞疾病治疗市场 - 地理洞察

疟疾和镰状细胞疾病治疗市场表现出多种模式，重要活动集中在受这些疾病影响不成比例的地区，特别是撒哈拉以南非洲和东南亚部分地区。在非洲，疟疾流行，镰状细胞病患疾病率很高，「减少疟疾伙伴关係」和国家疟疾控制计画等措施推动了对治疗和介入措施的需求。此外，改善医疗保健服务和加强医疗保健基础设施的努力也有助于这些地区的市场成长。在东南亚，印度和印尼等国家正在努力应对严重的疟疾负担，而镰状细胞疾病仍然是印度和奈及利亚等人口众多国家的问题。这些地区共同代表了疟疾和镰状细胞疾病治疗的主要市场，在对抗这些疾病和改善医疗保健的获取和提供方面的持续努力推动了市场扩张的机会。

疟疾与镰状细胞疾病治疗市场-竞争格局：

疟疾和镰状细胞疾病治疗市场是辉瑞、诺华和赛诺菲等製药巨头的战场。这些公司不断创新以保持领先地位，采取的策略包括推出新药（例如诺华公司的每日一次疟疾治疗药物）、收购有前途的公司（例如辉瑞公司收购镰状细胞疗法领导者Global Blood Therapeutics）以及大力投资研发下一代解决方案。这种激烈的竞争对患者来说是个好消息，因为它转化为不断改进的药物、更简单的治疗方案，并有望实现解决这两种疾病未被满足的需求的突破。

最近的发展：

2022年9月，Vertex Pharmaceuticals和CRISPR Therapeutics推出了一种名为「exa-cel」的基因疗法，用于治疗镰状细胞疾病。这种治疗涉及永久改变患者血细胞中的DNA，以帮助身体产生胎儿形式的血红蛋白，这种血红蛋白在出生时自然存在，但会转变为成人形式，而成人形式在镰状细胞病患者中是有缺陷的。

2023 年 12 月，美国食品药物管理局批准了两种具有里程碑意义的治疗方法 Casgevy 和 Lyfgenia，代表了第一种用于治疗 12 岁及以上患者镰状细胞疾病 (SCD) 的细胞基因疗法。

目录

第一章：疟疾和镰状细胞疾病治疗市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 疟疾和镰状细胞疾病治疗市场按疾病分類的片段
    • 按药物类型分類的疟疾和镰状细胞疾病治疗市场片段
    • 依给药途径分類的疟疾和镰状细胞疾病治疗市场片段
    • 按国家/地区分類的疟疾和镰状细胞疾病治疗市场片段
    • 按地区分類的疟疾和镰状细胞疾病治疗市场片段
  • 竞争洞察

第 3 章：疟疾和镰状细胞疾病治疗主要市场趋势

  • 疟疾和镰状细胞疾病治疗市场驱动因素
    • 市场驱动因素的影响分析
  • 疟疾和镰状细胞疾病治疗市场限制
    • 市场限制影响分析
  • 疟疾和镰状细胞疾病治疗市场机会
  • 疟疾和镰状细胞疾病治疗市场未来趋势

第 4 章：疟疾和镰状细胞疾病治疗产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：疟疾和镰状细胞疾病治疗市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：疟疾和镰状细胞疾病治疗市场格局

  • 2023 年疟疾和镰状细胞疾病治疗市场份额分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：疟疾和镰状细胞疾病治疗市场 - 按疾病分类

  • 概述
    • 按疾病分類的细分市场占有率分析
    • 疟疾
    • 镰形血球贫血症

第 8 章：疟疾和镰状细胞疾病治疗市场 - 按药物类型

  • 概述
    • 按药物类型分類的细分市场份额分析
    • 抗疟药
    • 疼痛管理药物
    • 疾病缓解疗法
    • 其他

第 9 章：疟疾和镰状细胞疾病治疗市场 - 按给药途径

  • 概述
    • 按给药途径分類的细分市场份额分析
    • 口服
    • 注射用

第 10 章：疟疾和镰状细胞疾病治疗市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美疟疾和镰状细胞疾病治疗主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模与预测（按疾病）
    • 北美市场规模和预测（按药物类型）
    • 北美市场规模与预测（按管理途径）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲疟疾和镰状细胞疾病治疗主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按疾病）
    • 欧洲市场规模和预测（按药物类型）
    • 欧洲市场规模与预测（按管理途径）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区疟疾和镰状细胞疾病治疗主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按疾病）
    • 亚太地区市场规模和预测（按药物类型）
    • 亚太地区市场规模与预测（依管理途径）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲疟疾和镰状细胞疾病治疗主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按疾病）
    • 拉丁美洲市场规模与预测（按药物类型）
    • 拉丁美洲市场规模与预测（按管理途径）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲疟疾和镰状细胞疾病治疗主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按疾病）
    • 中东和非洲市场规模及预测（按药物类型）
    • 中东和非洲市场规模及预测（按管理途径）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 疟疾和镰状细胞疾病治疗产业

  • 竞争仪表板
  • 公司简介
    • AbbVie Inc.
    • Alexion Pharmaceuticals, Inc. (acquired by AstraZeneca)
    • Bluebird bio Inc.
    • Celgene Corporation (acquired by Bristol Myers Squibb)
    • Emmaus Pharmaceuticals, Inc.
    • F. Hoffmann-La Roche Ltd
    • Gilead Sciences, Inc.
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • MacroGenics, Inc.
    • Merck & Co., Inc.
    • Novartis International AG
    • Pfizer Inc.
    • Sanofi SA
    • Sobi
    • Vertex Pharmaceuticals Incorporated
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV3025

REPORT HIGHLIGHT

Malaria and Sickle Cell Disease Treatment Market size was valued at USD 5,611.36 million in 2023, expanding at a CAGR of 25.9% from 2024 to 2032.

The Malaria and Sickle Cell Disease Treatment Market refers to the industry segment focused on the development and provision of therapies and interventions for combating malaria and managing sickle cell disease. The persistent global burden of malaria, particularly in tropical and subtropical regions, driving investments in research and development for innovative treatments and preventive measures. Additionally, the growing prevalence of sickle cell disease, especially in regions with high malaria transmission rates, further fuels market growth, prompting efforts to enhance disease management and develop curative therapies. However, restraints include the challenge of drug resistance in malaria treatment and the complexity of sickle cell disease management, compounded by limited access to healthcare in resource-constrained settings. Nevertheless, opportunities abound with advancements in precision medicine and gene therapy, promising novel approaches for personalized treatment and potential cures, thereby driving innovation and market expansion in the malaria and sickle cell disease treatment landscape.

Malaria and Sickle Cell Disease Treatment Market- Market Dynamics

Advancements in Treating Malaria and Sickle Cell Disease Amidst High Prevalence

Advancements in treating malaria and sickle cell disease amidst high prevalence are crucial for addressing the significant global health burden posed by these conditions. For instance, according to the World Health Organization (WHO), malaria affects over 200 million people worldwide annually. According to the Sickle Cell Disease Coalition, an estimated 300,000 children are born annually with sickle cell disease (SCD) worldwide. This number is expected to increase to 400,000 by 2050. In response, organizations like the National Institutes of Health (NIH) and the Bill & Melinda Gates Foundation are investing in research initiatives aimed at developing innovative treatments and preventive strategies. Recent breakthroughs include the approval of new antimalarial drugs like tafenoquine and the emergence of promising gene-editing therapies for sickle cell disease, underscoring the potential of advancements in healthcare to alleviate the burden of these diseases on affected populations worldwide.

Malaria and Sickle Cell Disease Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 25.9% over the forecast period (2024-2032)

Based on Disease segmentation, Sickle Cell Disease was predicted to show maximum market share in the year 2023

Based on Drug Type segmentation, Antimalarial Drugs was the leading type in 2023

Based on region, Asia Pacific was the leading revenue generator in 2023

Malaria and Sickle Cell Disease Treatment Market- Segmentation Analysis:

The Global Malaria and Sickle Cell Disease Treatment Market is segmented based on Disease, Drug Type, Route of Administration, and Region.

The market is divided into two categories based on Disease: Malaria and Sickle cell disease. Malaria prioritizes fast-acting drugs to combat rising cases and resistance, focusing on high-burden regions. Conversely, the sickle cell segment targets long-term management of chronic symptoms and improving patients' quality of life.

The market is divided into three categories based on Drug Type: Antimalarial Drugs, Pain Management Drugs, and Disease-Modifying Therapies. Antimalarial drugs dominate, targeting the parasite itself. Pain management drugs address a key symptom of sickle cell disease. The most promising segment is disease-modifying therapies, offering the potential to slow disease progression and improve long-term outcomes.

Malaria and Sickle Cell Disease Treatment Market- Geographical Insights

The Malaria and Sickle Cell Disease Treatment Market exhibits diverse patterns, with significant activity concentrated in regions disproportionately affected by these diseases, particularly in sub-Saharan Africa and parts of Southeast Asia. In Africa, where malaria is endemic and sickle cell disease prevalence is high, initiatives like the Roll Back Malaria Partnership and national malaria control programs drive demand for treatments and interventions. Additionally, efforts to improve access to healthcare and strengthen healthcare infrastructure contribute to market growth in these regions. In Southeast Asia, countries like India and Indonesia grapple with significant malaria burdens, while sickle cell disease remains a concern in countries with large populations such as India and Nigeria. These regions collectively represent key markets for malaria and sickle cell disease treatments, with opportunities for market expansion driven by ongoing efforts to combat these diseases and improve healthcare access and delivery.

Malaria and Sickle Cell Disease Treatment Market- Competitive Landscape:

The Malaria and Sickle Cell Disease treatment market is a battlefield for pharmaceutical giants like Pfizer, Novartis, and Sanofi. These companies are constantly innovating to stay ahead, with strategies like launching new drugs (e.g., Novartis' once-daily malaria treatment), acquiring promising companies (e.g., Pfizer's acquisition of sickle cell therapy leader Global Blood Therapeutics), and investing heavily in R&D for next-generation solutions. This fierce competition is good news for patients, as it translates into a constant flow of improved medications, easier treatment regimens, and hopefully, breakthroughs that address unmet needs in both diseases.

Recent Developments:

In September 2022, Vertex Pharmaceuticals and CRISPR Therapeutics launched a gene therapy called "exa-cel" for treating sickle cell disease. The treatment involves permanently changing DNA in a patient's blood cells to help the body produce a fetal form of hemoglobin, which is naturally present at birth but switches to an adult form that is defective in people with sickle cell disease.

In December 2023, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MALARIA AND SICKLE CELL DISEASE TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

AbbVie Inc.

Alexion Pharmaceuticals, Inc. (acquired by AstraZeneca)

Bluebird Bio Inc.

Celgene Corporation (acquired by Bristol Myers Squibb)

Emmaus Pharmaceuticals, Inc.

F. Hoffmann-La Roche Ltd

Gilead Sciences, Inc.

GlaxoSmithKline plc

Johnson & Johnson

MacroGenics, Inc.

Merck & Co., Inc.

Novartis International AG

Pfizer Inc.

Sanofi S.A.

Sobi

Vertex Pharmaceuticals Incorporated

Others

GLOBAL MALARIA AND SICKLE CELL DISEASE TREATMENT MARKET, BY DISEASE- MARKET ANALYSIS, 2019 - 2032

  • Malaria
  • Sickle cell disease

GLOBAL MALARIA AND SICKLE CELL DISEASE TREATMENT MARKET, BY DRUG TYPE- MARKET ANALYSIS, 2019 - 2032

  • Antimalarial Drugs
  • Pain Management Drugs
  • Disease-Modifying Therapies
  • Other

GLOBAL MALARIA AND SICKLE CELL DISEASE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Oral
  • Parenteral

GLOBAL MALARIA AND SICKLE CELL DISEASE TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Malaria and Sickle Cell Disease Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Malaria and Sickle Cell Disease Treatment Market Snippet by Disease
    • 2.1.2. Malaria and Sickle Cell Disease Treatment Market Snippet by Drug Type
    • 2.1.3. Malaria and Sickle Cell Disease Treatment Market Snippet by Route of Administration
    • 2.1.4. Malaria and Sickle Cell Disease Treatment Market Snippet by Country
    • 2.1.5. Malaria and Sickle Cell Disease Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Malaria and Sickle Cell Disease Treatment Key Market Trends

  • 3.1. Malaria and Sickle Cell Disease Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Malaria and Sickle Cell Disease Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Malaria and Sickle Cell Disease Treatment Market Opportunities
  • 3.4. Malaria and Sickle Cell Disease Treatment Market Future Trends

4. Malaria and Sickle Cell Disease Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Malaria and Sickle Cell Disease Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Malaria and Sickle Cell Disease Treatment Market Landscape

  • 6.1. Malaria and Sickle Cell Disease Treatment Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Malaria and Sickle Cell Disease Treatment Market - By Disease

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Disease, 2023 & 2032 (%)
    • 7.1.2. Malaria
    • 7.1.3. Sickle cell disease

8. Malaria and Sickle Cell Disease Treatment Market - By Drug Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Drug Type, 2023 & 2032 (%)
    • 8.1.2. Antimalarial Drugs
    • 8.1.3. Pain Management Drugs
    • 8.1.4. Disease-Modifying Therapies
    • 8.1.5. Other

9. Malaria and Sickle Cell Disease Treatment Market - By Route of Administration

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Route of Administration, 2023 & 2032 (%)
    • 9.1.2. Oral
    • 9.1.3. Parenteral

10. Malaria and Sickle Cell Disease Treatment Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Malaria and Sickle Cell Disease Treatment Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Malaria and Sickle Cell Disease Treatment Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Malaria and Sickle Cell Disease Treatment Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Malaria and Sickle Cell Disease Treatment Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Malaria and Sickle Cell Disease Treatment Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Malaria and Sickle Cell Disease Treatment Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. AbbVie Inc.
    • 11.2.2. Alexion Pharmaceuticals, Inc. (acquired by AstraZeneca)
    • 11.2.3. Bluebird bio Inc.
    • 11.2.4. Celgene Corporation (acquired by Bristol Myers Squibb)
    • 11.2.5. Emmaus Pharmaceuticals, Inc.
    • 11.2.6. F. Hoffmann-La Roche Ltd
    • 11.2.7. Gilead Sciences, Inc.
    • 11.2.8. GlaxoSmithKline plc
    • 11.2.9. Johnson & Johnson
    • 11.2.10. MacroGenics, Inc.
    • 11.2.11. Merck & Co., Inc.
    • 11.2.12. Novartis International AG
    • 11.2.13. Pfizer Inc.
    • 11.2.14. Sanofi S.A.
    • 11.2.15. Sobi
    • 11.2.16. Vertex Pharmaceuticals Incorporated
    • 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Malaria and Sickle Cell Disease Treatment Market: Disease Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Disease
  • TABLE Global Malaria and Sickle Cell Disease Treatment Market, by Disease 2019-2032 (USD Million)
  • TABLE Malaria and Sickle Cell Disease Treatment Market: Drug Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Type
  • TABLE Global Malaria and Sickle Cell Disease Treatment Market, by Drug Type 2019-2032 (USD Million)
  • TABLE Malaria and Sickle Cell Disease Treatment Market: Route of Administration Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Malaria and Sickle Cell Disease Treatment Market, by Route of Administration 2019-2032 (USD Million)
  • TABLE Malaria and Sickle Cell Disease Treatment Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Malaria and Sickle Cell Disease Treatment Market, by Region 2019-2032 (USD Million)
  • TABLE North America Malaria and Sickle Cell Disease Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Malaria and Sickle Cell Disease Treatment Market, by Disease, 2019-2032 (USD Million)
  • TABLE North America Malaria and Sickle Cell Disease Treatment Market, by Drug Type, 2019-2032 (USD Million)
  • TABLE North America Malaria and Sickle Cell Disease Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Europe Malaria and Sickle Cell Disease Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Malaria and Sickle Cell Disease Treatment Market, by Disease, 2019-2032 (USD Million)
  • TABLE Europe Malaria and Sickle Cell Disease Treatment Market, by Drug Type, 2019-2032 (USD Million)
  • TABLE Europe Malaria and Sickle Cell Disease Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Asia Pacific Malaria and Sickle Cell Disease Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Malaria and Sickle Cell Disease Treatment Market, by Disease, 2019-2032 (USD Million)
  • TABLE Asia Pacific Malaria and Sickle Cell Disease Treatment Market, by Drug Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Malaria and Sickle Cell Disease Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Latin America Malaria and Sickle Cell Disease Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Malaria and Sickle Cell Disease Treatment Market, by Disease, 2019-2032 (USD Million)
  • TABLE Latin America Malaria and Sickle Cell Disease Treatment Market, by Drug Type, 2019-2032 (USD Million)
  • TABLE Latin America Malaria and Sickle Cell Disease Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Malaria and Sickle Cell Disease Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Malaria and Sickle Cell Disease Treatment Market, by Disease, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Malaria and Sickle Cell Disease Treatment Market, by Drug Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Malaria and Sickle Cell Disease Treatment Market, by Route of Administration, 2019-2032 (USD Million)

List of Figures

  • FIGURE Malaria and Sickle Cell Disease Treatment Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Disease segment market share analysis, 2023 & 2032
  • FIGURE Disease segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Drug Type segment market share analysis, 2023 & 2032
  • FIGURE Drug Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Route of Administration segment market share analysis, 2023 & 2032
  • FIGURE Route of Administration segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Malaria and Sickle Cell Disease Treatment Market share and leading players, 2023
  • FIGURE Europe Malaria and Sickle Cell Disease Treatment Market share and leading players, 2023
  • FIGURE Asia Pacific Malaria and Sickle Cell Disease Treatment Market share and leading players, 2023
  • FIGURE Latin America Malaria and Sickle Cell Disease Treatment Market share and leading players, 2023
  • FIGURE Middle East and Africa Malaria and Sickle Cell Disease Treatment Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Malaria and Sickle Cell Disease Treatment Market share analysis by country, 2023
  • FIGURE Germany Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Malaria and Sickle Cell Disease Treatment Market share analysis by country, 2023
  • FIGURE India Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Malaria and Sickle Cell Disease Treatment Market share analysis by country, 2023
  • FIGURE Brazil Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Malaria and Sickle Cell Disease Treatment Market share analysis by country, 2023
  • FIGURE Saudi Arabia Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)